Prospects for a dengue virus vaccine

被引：444

作者：

Whitehead, Stephen S.

Blaney, Joseph E.

Durbin, Anna P.

Murphy, Brian R.

机构：

[1] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA

[2] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD 21205 USA

来源：

NATURE REVIEWS MICROBIOLOGY | 2007年 / 5卷 / 07期

关键词：

D O I：

10.1038/nrmicro1690

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The number of cases of severe dengue disease continues to grow in endemic areas of southeast Asia, Central and South America, and other subtropical regions. Children bear the greatest burden of disease, and the development of an effective vaccine remains a global public health priority. A tetravalent vaccine is urgently needed and must be effective against all four dengue virus serotypes, be cost-effective and provide long-term protection. In this Review we discuss the unique immunological concerns in dengue virus vaccine development and the current prospects for the development of an acceptable vaccine, a goal that is likely to be reached in the near future.

引用

页码：518 / 528

页数：11

共 119 条

[81]

NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P392

[82]

NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P398

[83] UNUSUAL NEUROLOGIC MANIFESTATIONS OCCURRING DURING DENGUE FEVER INFECTION [J].

PATEY, O ;

OLLIVAUD, L ;

BREUIL, J ;

LAFAIX, C .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 48 (06) :793-802

[84] Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in Thai children [J].

Pengsaa, Krisana ;

Luxemburger, Christine ;

Sabchareon, Arunee ;

Limkittikul, Kriengsak ;

Yoksan, Sutee ;

Chambonneau, Laurent ;

Chaovarind, Udom ;

Sirivichayakul, Chukiat ;

Lapphra, Keswadee ;

Chanthavanich, Pornthep ;

Lang, Jean .

JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (11) :1570-1576

[85] ULTRASOUND FINDINGS IN DENGUE HEMORRHAGIC-FEVER [J].

PRAMULJO, HS ;

HARUN, SR .

PEDIATRIC RADIOLOGY, 1991, 21 (02) :100-102

[86] An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model [J].

Putnak, JR ;

Coller, BA ;

Voss, G ;

Vaughn, DW ;

Clements, D ;

Peters, I ;

Bignami, G ;

Houng, HS ;

Chen, RCM ;

Barvir, DA ;

Seriwatana, J ;

Cayphas, S ;

Garçon, N ;

Gheysen, D ;

Kanesa-thasan, N ;

McDonell, M ;

Humphreys, T ;

Eckels, KH ;

Prieels, JP ;

Innis, BL .

VACCINE, 2005, 23 (35) :4442-4452

[87] Development of a purified, inactivated, dengue-2 virus vaccine prototype in vero cells: Immunogenicity and protection in mice and rhesus monkeys [J].

Putnak, R ;

Barvir, DA ;

Burrous, JM ;

Dubois, DR ;

DAndrea, VM ;

Hoke, CH ;

Sadoff, JC ;

Eckels, KH .

JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1176-1184

[88]

Putnak R, 1996, AM J TROP MED HYG, V55, P504

[89] Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys [J].

Raviprakash, K ;

Ewing, D ;

Simmons, M ;

Porter, KR ;

Jones, TR ;

Hayes, CG ;

Stout, R ;

Murphy, GS .

VIROLOGY, 2003, 315 (02) :345-352

[90]

Rodhain Francois, 1997, P45

← 3 4 5 6 7 8 9 10 11 12 →